SCHEMBL7598443

SCHEMBL7598443

Cc1c(C)c2c(C)c3c(CN)coc3cc2oc1=O

nearest known ligand 0.44

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH2 P05091 3/20 0.44
THRB P10828 1/20 0.37
HPGD P15428 6/20 0.36
TSHR P16473 3/20 0.36
ALDH1A1 P00352 10/20 0.36
KDM4E B2RXH2 9/20 0.36
HSD17B10 Q99714 6/20 0.36
MAPK1 P28482 1/20 0.36
ALDH1A2 O94788 2/20 0.36
ALDH1B1 P30837 2/20 0.36
ALDH1A3 P47895 2/20 0.36
MAPT P10636 1/20 0.34
LMNA P02545 3/20 0.34
MAOA P21397 1/20 0.34
BRD4 O60885 1/20 0.33
POLB P06746 2/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5903908 0.85 ALDH2 (0.44) ALDH2THRBHPGDTSHRALDH1A1
SCHEMBL10550597 0.85 ALDH2 (0.44) ALDH2THRBHPGDTSHRALDH1A1
SCHEMBL9277301 0.79 ALDH2 (0.63) ALDH2THRBHPGDTSHRALDH1A1
SCHEMBL698745 0.72 ALDH2 (0.45) ALDH2THRBHPGDTSHRALDH1A1
SCHEMBL10548888 0.68 ALDH2 (0.45) ALDH2THRBHPGDTSHRALDH1A1
SCHEMBL17525029 0.67 ALDH2 (0.59) ALDH2THRBHPGDTSHRALDH1A1
SCHEMBL7000371 0.65 MAOA (0.60) ALDH2HPGDTSHRALDH1A1KDM4E
SCHEMBL3939905 0.65 KDM4E (0.43) ALDH2THRBHPGDTSHRALDH1A1
SCHEMBL1002679 0.65 CYP3A4 (0.49) ALDH2THRBHPGDTSHRALDH1A1
SCHEMBL27907872 0.64 ALDH2 (0.47) ALDH2HPGDTSHRALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104027809-B Treat the method and system of cell proliferation disorders 免疫之光有限责任公司 2017-08-25 CN disclosed
CN-104027809-A METHODS AND SYSTEMS FOR TREATING CELL PROLIFERATION DISORDERS IMMUNOLIGHT LLC 2014-09-10 CN disclosed
CN-101711246-B Methods and systems for treating cell proliferative disorders IMMUNOLIGHT LLC 2014-06-25 CN disclosed
CN-101711246-A Methods and systems for treating cell proliferative disorders IMMUNOLIGHT LLC 2010-05-19 CN disclosed
US-20020028455-A1 Methods and reagents for assembling molecules on solid supports MASSACHUSETTS INSTITUTE OF TECHNOLOGY 2002-03-07 US disclosed
WO-2001083826-A2 METHODS AND REAGENTS FOR ASSEMBLING MOLECULES ON SOLID SUPPORTS MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2001-11-08 WO disclosed
US-5665541-A Formation of triple helix complexes for the detection of double stranded DNA sequences using oligomers which comprise an 8-modified purine base THE JOHNS HOPKINS UNIVERSITY (US) 1997-09-09 US disclosed
US-5514707-A Inhibition of smooth muscle cell proliferation by 8-methoxypsoralen photoactivated by visible light YALE UNIVERSITY (US) 1996-05-07 US disclosed
EP-0672171-A1 FORMATION OF TRIPLE HELIX COMPLEXES OF DOUBLE STRANDED DNA USING NUCLEOSIDE OLIGOMERS WHICH COMPRISE PURINE BASE ANALOGS THE JOHNS HOPKINS UNIVERSITY (US) 1995-09-20 EP disclosed
EP-0650526-A1 FORMATION OF TRIPLE HELIX COMPLEXES OF SINGLE STRANDED NUCLEIC ACIDS USING NUCLEOSIDE OLIGOMERS THE JOHNS HOPKINS UNIVERSITY (US) 1995-05-03 EP disclosed
US-5354774-A Aftertreatment angioplasty YALE UNIVERSITY (US) 1994-10-11 US disclosed
WO-1993007295-A1 FORMATION OF TRIPLE HELIX COMPLEXES OF SINGLE STRANDED NUCLEIC ACIDS USING NUCLEOSIDE OLIGOMERS THE JOHNS HOPKINS UNIVERSITY (US) 1993-04-15 WO disclosed
WO-1993005180-A1 FORMATION OF TRIPLE HELIX COMPLEXES OF DOUBLE STRANDED DNA USING NUCLEOSIDE OLIGOMERS WHICH COMPRISE PURINE BASE ANALOGS THE JOHNS HOPKINS UNIVERSITY (US) 1993-03-18 WO disclosed
EP-0266099-A2 Oligonucleoside alkyl or arylphosphonate derivatives capable of crosslinking with or cleaving nucleic acids THE JOHNS HOPKINS UNIVERSITY (US) 1988-05-04 EP disclosed